Funding sources None.
Psoriasis: an evidence-based update. Report of the 9th Evidenced Based Update Meeting, 12 May 2011, Loughborough, U.K.
Article first published online: 23 JAN 2012
© 2011 The Authors. BJD © 2011 British Association of Dermatologists
British Journal of Dermatology
Volume 166, Issue 2, pages 252–260, February 2012
How to Cite
De Mozzi, P., Johnston, G.A. and Alexandroff, A.B. (2012), Psoriasis: an evidence-based update. Report of the 9th Evidenced Based Update Meeting, 12 May 2011, Loughborough, U.K. British Journal of Dermatology, 166: 252–260. doi: 10.1111/j.1365-2133.2011.10767.x
Conflicts of interests Proceeds from Evidence Based Update Meetings are donated to the U.K. Dermatology Clinical Trials Network (DCTN). This meeting was generously supported by Leo Pharma, Galderma, Pfizer, Janssen-Cilag. A.B.A. is a member of the Comprehensive Local. Research Networks Dermatology Specialty Group, Biologics for Psoriasis Industry Subgroup, and the Steering Group of the U.K. DCTN; he has received fellowships from Procter & Gamble, plus educational grants, acted as an investigator or served on the advisory board for Pfizer, Merck Serono, LEO Pharma, Basilea Pharmaceutica Ltd, Genus Pharmaceuticals Ltd, Almirall and Galderma.
- Issue published online: 23 JAN 2012
- Article first published online: 23 JAN 2012
- Accepted for publication 11 October 2011
The Centre of Evidence Based Dermatology, University of Nottingham, U.K. holds an annual Evidence Based Update (EBU) Meeting focused on important dermatological topics, which have in the past included eczema, urticaria, blistering disorders, skin infections, skin cancer and hair disorders. These one-day meetings aim to summarize the most recent evidence in the form of systematic reviews and recently completed clinical trials. This year, the 9th EBU meeting took place in Loughborough, U.K. on 12 May 2011 and was devoted to psoriasis. The latest updates on topical treatments, nail psoriasis, genetics and clinical implications, rational use of biologics, new and unpublished studies on combination of phototherapy and biologics for psoriasis, and on treatments of palmoplantar pustular psoriasis were discussed by a panel of renowned international speakers.